# Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements

> **NCT01272830** · PHASE2 · COMPLETED · sponsor: **IC-MedTech Corporation** · enrollment: 57 (actual)

## Conditions studied

- Edematous
- Synovitis
- Foreign Body Reaction
- Osteolysis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Apatone®B

## Key facts

- **NCT ID:** NCT01272830
- **Lead sponsor:** IC-MedTech Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2018-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01272830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01272830, "Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01272830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*